(Q79839141)
Statements
An analysis of clinical trials assessing the efficacy and safety of single-agent thalidomide in patients with relapsed or refractory multiple myeloma (English)
H Miles Prince
Brad Schenkel
Linda Mileshkin
scientific article published on 01 January 2007